LIRENTELIMAB

UNII:	SWS48LJU3T
Formula:
Preferred Substance Name:	LIRENTELIMAB

2283348-97-8
AK002
AK-002
ANTOLIMAB
IMMUNOGLOBULIN G1, ANTI-(HUMAN SIALIC ACID-BINDINGE IG-LIKE LECTIN 8) (HUMAN-MUS MUSCULUS MONOCLONAL AK002 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AK002 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS SIALIC ACID-BINDING IG-LIKE LECTIN 8 (SIALOADHESIN FAMILY MEMBER 2, SIGLEC-8, SAF-2))HUMANIZED MOUSE MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-450) (VH (HOMO SAPIENS IGHV3-66*01 (79%) (IGHD)-IGHJ5*01 (91%)/MUS MUSCULUS IGHV2-9*02 (74%) (IGHD)-IGHJ2*01 (85%))) (8.7.14) (1-120)-HOMO SAPIENS IGHG1*03 (CH3(K107>DEL(450))) (121-449)) (223-213')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-213') (HOMO SAPIENS/MUS MUSCULUS V-KAPPA (HOMO SAPIENS IGKV3-11*01 (86%) IGKJ3*01 (92%)/(MUS MUSCULUS IGKV4-57*01 (77%) IGKJ4*01 (83%))(5.3.15) (1'-106')-HOMO SAPIENS IGKC*01 (107'-213')), DIMER (229-229'':232-232'')-BISDISULFIDE
LIRENTELIMAB [INN]
LIRENTELIMAB [USAN]
LIRENTELIMAB [WHO-DD]
MONOCLONAL ANTIBODY AK002

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LIRENTELIMAB

Synonyms and Mappings

Resources